FDA AuthorisationBUBS AUSTRALIA LIMITED10 Sep 2026Joe Coote – CEOChris Rowe – CFOJasmin Manner – President - USADisclaimerThis presentation is in summary form and is not necessarily complete. It should be read together with the Company’s other announcements lodged with the Australian...
FDA Approval Webinar Presentation
Filed with ASX ·
Watch Bubs Australia's latest callBubs Australia (ASX:BUB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Bubs Australia (ASX:BUB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Bubs Australia
- FDA Approval Webinar Notification
- Bubs Secures Permanent US FDA Approval for Infant Formula
- Trading Halt
- Pause in Trading
- Change of Director's Interest Notice - LTM
Later from Bubs Australia
- Response to ASX Aware Query
- Date of AGM and Closing Date for Director Nominations
- Change of Director's Interest Notice - PJ
- Application for quotation of securities - BUB
- Cleansing Notice
Follow Bubs Australia into a list and get an email when it puts out news.
Follow Bubs Australia